Collaborative Research: BMAT: Adapting Cas9 Protein from CRISPR as a Structural Unit for Molecular Assembly

合作研究：BMAT：将 CRISPR 中的 Cas9 蛋白改造为分子组装的结构单元

• 批准号: 1709010
• 负责人: Thomas LaBean
• 金额: $ 21万
• 依托单位: North Carolina State University
• 依托单位国家: 美国
• 项目类别: Continuing Grant
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-07-01 至 2021-06-30
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1709010&HistoricalAwards=false
• 关键词: Collaborative; Research; BMAT; Adapting; Cas9

NON-TECHNICAL Even with very advanced lithographic techniques, it is difficult or impossible for human engineering to reach down and control matter in the nanometer length-scale. However, biological systems utilize the ability of molecules to recognize and bind to one another for self-assembling very complex structures with feature sizes down in the nanometer range. Taking inspiration from the rich diversity of functional architectures observed in biology and making use of new discoveries in engineered biomaterials, this project will expand basic understanding of biomaterials and their programmable assembly. Successful completion of the research will, in the short-term, enable significant progress in nano-scale self-assembly using proteins and nucleic acids. In the long-term, this will provide the needed technology for implementation of ever-smaller devices for computing, communications, and sensing applications; implantable medical devices and biosensors; and programmable, artificial molecular machines. This project will provide training opportunities for postgraduate and postdoctoral students in cutting-edge molecular engineering and bionanotechnology. Using NSF's supplemental funding mechanisms, high school and undergraduate students will be attracted to the project to participate research and to train in the emerging field of nanoscience. This project will expand our scientific understanding of nanometer-scale phenomena and materials as well as to improve our ability to design and engineer new functional materials on this length-scale. The results of this project could impact future application areas in the sustainable fabrication of electronic devices and new approaches to medical diagnostics and therapeutics. TECHNICAL DNA's capacity for highly reliable and programmable molecular recognition has led to the field of DNA-based nanotechnology, also known as structural DNA nanotechnology. Researchers in this field develop materials and techniques for DNA-guided molecular and nano-scale self-assembly and have made remarkable recent progress, including the ordering of matter with unprecedented precision and parallelism, nano-scale organization of proteins and metal particles, as well as fascinating demonstrations of artificial molecular machines. One problem that has limited DNA nanotech's translation from prototype demonstrations to commercially viable applications has been the lack of a general purpose, rapidly-reprogrammable method for functionalizing DNA structures with polypeptides. The Cas9 protein from the CRISPR RNA-directed bacterial immune system is used here as a novel solution to this problem. Cas9 is a programmable protein that acts as an endonuclease for cleaving non-self nucleic acid targets. In an engineered form, dCas9 has been mutated to bind a DNA sequence (specified by an RNA molecule) without cleavage of the targeted DNA. The dCas9 protein, guide RNA, and its target DNA sequences are well understood, modular, and programmable. Consequently, dCas9 is perfect for use in the development of a new family of molecular assembly tools with designed sequence specificities and the ability to act as a new smart glue for the programmed assembly of other nanomaterials including protein enzymes, affinity peptides, inorganic nanoparticles, and carbon nanotubes. The overarching goal of the project is to add the programmable recognition and binding functions of dCas9 to the growing toolbox of materials and methods available to DNA-based nanotech. Specifically, the project seeks to develop fusion proteins bearing mutant Cas9 domains to organize other polypeptides (including ligands, in vitro selected affinity peptides, enzymes, and inhibitors) on DNA nanostructures in programmed patterns for biomedical applications as well as in the bionanofabrication of electronic and photonic devices.

即使有非常先进的光刻技术，人类工程学也很难或不可能在纳米尺度上深入并控制物质。然而，生物系统利用分子相互识别和结合的能力来自组装非常复杂的结构，特征尺寸在纳米范围内。从生物学中观察到的丰富多样性的功能结构中获得灵感，并利用工程生物材料的新发现，该项目将扩大对生物材料及其可编程组装的基本理解。这项研究的成功完成将在短期内使使用蛋白质和核酸的纳米级自组装取得重大进展。从长远来看，这将为实现用于计算、通信和传感应用的越来越小的设备提供所需的技术；植入式医疗设备和生物传感器；以及可编程的人造分子机器。该项目将为研究生和博士后提供尖端分子工程和生物纳米技术方面的培训机会。利用NSF的补充资助机制，高中生和本科生将被吸引到该项目中，参与研究并在新兴的纳米科学领域进行培训。该项目将扩大我们对纳米尺度现象和材料的科学理解，并提高我们在这种长度尺度上设计和设计新功能材料的能力。该项目的结果可能会影响未来电子设备可持续制造的应用领域，以及医疗诊断和治疗的新方法。技术DNA的高度可靠和可编程的分子识别能力导致了基于DNA的纳米技术领域，也被称为结构DNA纳米技术。该领域的研究人员开发了DNA引导的分子和纳米级自组装的材料和技术，并取得了令人瞩目的最新进展，包括以前所未有的精度和平行度对物质进行排序，蛋白质和金属颗粒的纳米级组织，以及令人着迷的人工分子机器演示。限制DNA纳米技术从原型演示转化为商业可行应用的一个问题是，缺乏一种通用的、快速可重编程的方法来用多肽使DNA结构功能化。来自CRISPR RNA指导的细菌免疫系统的Cas9蛋白在这里被用来作为这个问题的新解决方案。Cas9是一种可编程的蛋白质，作为切割非自身核酸靶标的内切酶。在一种工程形式中，dCas9已被突变，以结合DNA序列(由RNA分子指定)，而不切割目标DNA。DCas9蛋白、引导RNA及其靶DNA序列是很容易理解的、模块化的和可编程的。因此，dCas9非常适合用于开发新的分子组装工具家族，具有设计的序列特异性，并能够作为一种新的智能粘合剂，用于其他纳米材料的程序化组装，包括蛋白质酶、亲和肽、无机纳米颗粒和碳纳米管。该项目的首要目标是将dCas9的可编程识别和结合功能添加到基于DNA的纳米技术可用的不断增长的材料和方法工具箱中。具体地说，该项目旨在开发含有突变的Cas9结构域的融合蛋白，以在DNA纳米结构上以编程模式组织其他多肽(包括配体、体外选择的亲和肽、酶和抑制剂)，用于生物医学以及电子和光子设备的生物纳米制造。